115 related articles for article (PubMed ID: 21801844)
21. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
[TBL] [Abstract][Full Text] [Related]
22. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.
Wong D; Dorovini-Zis K; Vincent SR
Exp Neurol; 2004 Dec; 190(2):446-55. PubMed ID: 15530883
[TBL] [Abstract][Full Text] [Related]
23. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.
Marcondes S; Cardoso MH; Morganti RP; Thomazzi SM; Lilla S; Murad F; De Nucci G; Antunes E
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3434-9. PubMed ID: 16492779
[TBL] [Abstract][Full Text] [Related]
24. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
[TBL] [Abstract][Full Text] [Related]
25. Cyclic GMP as a second messenger in the nitric oxide-mediated conidiation of the mycoparasite Coniothyrium minitans.
Li B; Fu Y; Jiang D; Xie J; Cheng J; Li G; Hamid MI; Yi X
Appl Environ Microbiol; 2010 May; 76(9):2830-6. PubMed ID: 20208018
[TBL] [Abstract][Full Text] [Related]
26. Cyclic guanosine monophosphate dependent pathway contributes to human mast cell inhibitory actions of the nitric oxide donor, diethylamine NONOate.
Yip KH; Huang Y; Leung FP; Lau HY
Eur J Pharmacol; 2010 Apr; 632(1-3):86-92. PubMed ID: 20096283
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
Tsikas D; Ikic M; Tewes KS; Raida M; Frölich JC
FEBS Lett; 1999 Jan; 442(2-3):162-6. PubMed ID: 9928994
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide regulates steroid synthesis by bovine antral granulosa cells in a chemically defined medium.
Faes MR; Caldas-Bussiere MC; Viana KS; Dias BL; Costa FR; Escocard RM
Anim Reprod Sci; 2009 Feb; 110(3-4):222-36. PubMed ID: 18372125
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite.
Brown AS; Moro MA; Masse JM; Cramer EM; Radomski M; Darley-Usmar V
Cardiovasc Res; 1998 Nov; 40(2):380-8. PubMed ID: 9893732
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
Asplund Persson A; Zalavary S; Lindström E; Whiss PA; Bengtsson T; Grenegård M
Eur J Pharmacol; 2005 Jul; 517(3):149-57. PubMed ID: 15963495
[TBL] [Abstract][Full Text] [Related]
31. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
[TBL] [Abstract][Full Text] [Related]
32. NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium.
Fleischhauer JC; Bény JL; Flammer J; Haefliger IO
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1759-63. PubMed ID: 10845596
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide reduces T lymphocyte adhesion to human brain microvessel endothelial cells via a cGMP-dependent pathway.
Wong D; Prameya R; Wu V; Dorovini-Zis K; Vincent SR
Eur J Pharmacol; 2005 May; 514(2-3):91-8. PubMed ID: 15910796
[TBL] [Abstract][Full Text] [Related]
34. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
Crane MS; Rossi AG; Megson IL
Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
Martinez A; Salas E; Radomski A; Radomski MW
Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
[TBL] [Abstract][Full Text] [Related]
36. Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP.
Sanchez JJ; Abreu P; Gonzalez MC
Eur J Pharmacol; 2002 Mar; 438(1-2):79-83. PubMed ID: 11906714
[TBL] [Abstract][Full Text] [Related]
37. Effects of manipulating the nitric oxide/cyclic GMP pathway on bovine oocyte meiotic resumption in vitro.
Bilodeau-Goeseels S
Theriogenology; 2007 Sep; 68(5):693-701. PubMed ID: 17604095
[TBL] [Abstract][Full Text] [Related]
38. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
